Literature DB >> 25876833

Possible therapeutic impact of the iron chelation on renal fibrosis.

Kouichi Tamura1, Kazushi Uneda1, Kengo Azushima1, Hiromichi Wakui1, Kotaro Haruhara2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25876833     DOI: 10.1038/hr.2015.60

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  14 in total

Review 1.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

2.  Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients.

Authors:  Kotaro Haruhara; Nobuo Tsuboi; Kentaro Koike; Akira Fukui; Yoichi Miyazaki; Tetsuya Kawamura; Makoto Ogura; Takashi Yokoo
Journal:  Hypertens Res       Date:  2014-09-18       Impact factor: 3.872

3.  Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Shinichi Hirotani; Tohru Masuyama
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

4.  Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice.

Authors:  Hisashi Sawada; Yoshiro Naito; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Shinichi Hirotani; Tohru Masuyama
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

Review 5.  Mechanisms of tubulointerstitial fibrosis.

Authors:  Masayuki Iwano; Eric G Neilson
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-05       Impact factor: 2.894

6.  Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Shinichi Hirotani; Toshihiro Iwasaku; Akiyo Eguchi; Mitsumasa Ohyanagi; Takeshi Tsujino; Tohru Masuyama
Journal:  J Hypertens       Date:  2012-11       Impact factor: 4.844

Review 7.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

Review 8.  Origin of myofibroblasts and cellular events triggering fibrosis.

Authors:  Matthias Mack; Motoko Yanagita
Journal:  Kidney Int       Date:  2014-08-27       Impact factor: 10.612

9.  Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Shinichi Hirotani; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Mitsumasa Ohyanagi; Takeshi Tsujino; Tohru Masuyama
Journal:  J Hypertens       Date:  2013-06       Impact factor: 4.844

10.  Age and association of kidney measures with mortality and end-stage renal disease.

Authors:  Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

View more
  3 in total

Review 1.  The Cross-Link between Ferroptosis and Kidney Diseases.

Authors:  Jingyu Wang; Yi Liu; Yaqing Wang; Li Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-03       Impact factor: 6.543

Review 2.  COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.

Authors:  Carlo Perricone; Elena Bartoloni; Roberto Bursi; Giacomo Cafaro; Giacomo Maria Guidelli; Yehuda Shoenfeld; Roberto Gerli
Journal:  Immunol Res       Date:  2020-08       Impact factor: 2.829

Review 3.  Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.

Authors:  Xiaoqin Zhang; Xiaogang Li
Journal:  Metabolites       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.